Recovery of Investigational New Drugs From Clinical Investigators; Revised Compliance Policy Guide; Availability

Summary

The Food and Drug Administration (FDA) has released an updated compliance policy guide (CPG) 7132c.05, titled 'Recovery of Investigational New Drugs from Clinical Investigators,' which clarifies the terminology for recovering investigational new drugs from clinical investigators and supersedes outdated references. This revised policy continues to apply to new animal drugs being studied under investigational new animal drug applications.